Erbitux cetuximab: Phase III data

In a Phase III trial (NCIC CTG CO.17) in 572 patients, Erbitux plus

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE